Delivery Order SPE2DP26D0003-SPE2DP26F4178

<p>The Defense supply chain organization (Medical Supply Chain) issued a $2,383.65 delivery order to Sanofi Vaccines US Inc. on April 2, 2026, for influenza virus vaccine, with ultimate completion by April 17, 2026.</p> <p>Place of performance is Swiftwater, Pennsylvania. The order is priced firm fixed price with no set-aside designation.</p>

<p>The Defense Department's Medical Supply Chain issued a $11,282.61 delivery order to Sanofi Vaccines US Inc. on January 26, 2026, for influenza virus vaccine.</p> <p>Place of performance is Swiftwater, PA 18370. The order is firm fixed price with an ultimate completion date of March 31, 2026. No set-aside was used. The source does not identify the parent IDV or GWAC under which this delivery order was issued.</p>

<p>The Department of Defense Medical Supply Chain issued a delivery order to Sanofi Vaccines US Inc. on February 20, 2026, with a ceiling value of $824,486 for influenza virus vaccine supply.</p> <p>Place of performance is Swiftwater, PA 18370. The order is firm fixed price with an ultimate completion date of September 25, 2026. No set-aside was used for this delivery order.</p>

<p>The Department of Defense Medical Supply Chain issued a $2.92 million delivery order to Sanofi Vaccines US Inc. on February 20, 2026, for influenza virus vaccine procurement. The order is firm fixed price with an ultimate completion date of September 25, 2026. Place of performance is Swiftwater, PA 18370.</p>

The U.S. Department of Defense Medical Supply Chain awarded a $486,741.33 firm fixed-price delivery order to Sanofi Vaccines US Inc. (division of Sanofi Pasteur Inc.) on December 12, 2025, for the procurement of influenza virus vaccine. The contract, which carries no set-aside designation, is scheduled for completion by March 31, 2026, and will be performed at the contractor's facility in Swiftwater, Pennsylvania. Sanofi Pasteur Inc. is a foreign-owned pharmaceutical manufacturer and established...

The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $2,990.79 firm fixed-price delivery order to Sanofi Pasteur Inc. for influenza virus vaccine on April 15, 2025. The contract, with an ultimate completion date of April 18, 2025, does not utilize any set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, is a critical supplier of vaccines and medical countermeasures to multiple federal...

<p>The Defense Logistics Agency Troop Support Medical awarded Sanofi Pasteur Inc., operating as the Sanofi Pasteur Inc. Division, a $2,529,380.70 firm fixed price delivery order contract to provide Influenza Virus Vaccines. The place of performance will be Swiftwater, Pennsylvania and the period of performance is from March 8, 2023 through October 13, 2023. No applicable subcontractors were identified.</p>

The U.S. Department of Defense Medical Supply Chain has awarded a $1,153.52 firm fixed-price purchase order to Sanofi Pasteur Inc. for influenza virus vaccine. The award, issued on October 2, 2025, with an ultimate completion date of October 7, 2025, represents a small-value delivery order with no set-aside designation. Sanofi Pasteur Inc., a foreign-owned pharmaceutical manufacturer headquartered in Swiftwater, Pennsylvania, serves as the prime contractor and will fulfill this requirement...

The U.S. government awarded a delivery order contract (No. 36E79726D0009) to Sanofi Vaccines US Inc., a division of Sanofi Pasteur Inc., for the procurement of influenza virus vaccine for the 2026-2027 season. This firm fixed-price contract, issued without set-aside designation, carries a ceiling value of $3,810.72 and was awarded on March 4, 2026, with an ultimate completion date of September 15, 2026. The contract will be performed at Sanofi Pasteur's facility in Swiftwater, Pennsylvania,...

The U.S. government awarded a $1,457.04 firm fixed-price delivery order to Sanofi Vaccines US Inc. (operating under its division Sanofi Pasteur Inc.) on March 17, 2026, for the provision of staff influenza vaccines. The contract, designated as a mandatory national contract (36E79726D0009), is set to be completed by September 30, 2026, with performance taking place in Swiftwater, Pennsylvania. The Federal Medical Center Rochester, a civilian facility, serves as the funding agency for this vaccine...